Cargando…
Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease
BACKGROUND: The role of Mycobacterium avium paratuberculosis [MAP] in inflammatory bowel disease [IBD], especially Crohn’s disease [CD] is controversial due conflicting results and lack of reproducibility and standardised tests. The current study focuses on the role of MAP in disease progression and...
Autores principales: | van der Sloot, Kimberley W J, Voskuil, Michiel D, Blokzijl, Tjasso, Dinkla, Annemieke, Ravesloot, Lars, Visschedijk, Marijn C, van Dullemen, Hendrik M, Festen, Eleonora A M, Alizadeh, Behrooz Z, van Leer-Buter, Coretta, Weersma, Rinse K, van Goor, Harry, Koets, Ad P, Dijkstra, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496491/ https://www.ncbi.nlm.nih.gov/pubmed/33378524 http://dx.doi.org/10.1093/ecco-jcc/jjaa263 |
Ejemplares similares
-
Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease
por: Otten, Antonius T., et al.
Publicado: (2022) -
Effects of Age and Environment on Adaptive Immune Responses to Mycobacterium avium subsp. paratuberculosis (MAP) Vaccination in Dairy Goats in Relation to Paratuberculosis Control Strategies
por: Koets, Ad, et al.
Publicado: (2019) -
Environmental factors associated with biological use and surgery in inflammatory bowel disease
por: van der Sloot, Kimberley W J, et al.
Publicado: (2020) -
Classification and prediction of Mycobacterium Avium subsp. Paratuberculosis (MAP) shedding severity in cattle based on young stock heifer faecal microbiota composition using random forest algorithms
por: Umanets, Alexander, et al.
Publicado: (2021) -
Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease
por: Karmi, Naomi, et al.
Publicado: (2021)